mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
7e-05 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
7e-05 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
9e-05 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0001 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
mRNA |
Panobinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0002 |
mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |